@article{article, title  = {{Safety of tralokinumab in pediatric patients aged 12-17 years with moderate to severe atopic dermatitis: results from the phase 3 ECZTRA 6 trial}},

 publisher = {{National Society for Cutaneous Medicine}},

 url = {{http://dx.doi.org/10.25251/skin.7.supp.140 }},

 year = {{2023}},

 month = {{3}},

 author = {{Wollenberg A and Cork M and Flohr C and Bewley A and Blauvelt A and Hong C-H and Imafuku S and Schuttelaar MLA and Simpson E and Soong W and Amoudruz P et al}},

 doi = {{10.25251/skin.7.supp.140}},

 volume = {{7}},

 journal = {{SKIN The Journal of Cutaneous Medicine}},

 issue = {{2}},

 pages = {{s140-s140}},

 note = {{Accessed on 2024/12/22}}}